CLINICAL_TRIALS
trial_result
· 2011-01-11
Clinical Trial Update: Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents [Phase 3]
Summary
A Phase 3 clinical trial comparing morning dosing of Lantus (insulin glargine) to other insulins in adolescents with Type 1 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED